Austin

Running trials

• Recruiting

  A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  NCT07459647· Phase 2· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  NCT06887192· Phase 2· Source

• Active, not recruiting

  Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  NCT06641089· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia2 recruiting
• Alzheimer disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

  NCT07038876· Phase 2· Source

• Completed

  Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

  NCT06462586· Phase 3· Source

• Completed

  A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

  NCT06190093· Phase 3· Source

• Completed

  Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

  NCT05766813· Phase 2· Source

• Completed

  An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT05061719· Phase 3· Source

• Completed

  Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT04985942· Phase 3· Source

• Completed

  Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

  NCT04959032· Phase 3· Source